{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:49:46Z","timestamp":1791409786692,"version":"4.3.3"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100027495","name":"Education Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027495","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Pacing and Electrophysiology Journal"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ipej.2026.09.010","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:27:29Z","timestamp":1790098049000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodality assessment for sudden cardiac death risk stratification in non-ischemic cardiomyopathy: A case-based framework integrating cardiac magnetic resonance, electrophysiologic observations, and genetics"],"prefix":"10.1016","author":[{"given":"Michael J.","family":"Litt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Oraii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fermin C.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8369-0259","authenticated-orcid":false,"given":"Saman","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9276-4857","authenticated-orcid":false,"given":"David S.","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7962-9423","authenticated-orcid":false,"given":"Francis E.","family":"Marchlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ipej.2026.09.010_bib1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jcmg.2018.03.006","article-title":"The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis","volume":"11","author":"Becker","year":"2018","journal-title":"JACC, Cardiovasc Imaging"},{"key":"10.1016\/j.ipej.2026.09.010_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jcmg.2016.01.033","article-title":"Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis","volume":"9","author":"Disertori","year":"2016","journal-title":"JACC, Cardiovasc Imaging"},{"key":"10.1016\/j.ipej.2026.09.010_bib3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib4","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/eurheartj\/ehaf464","article-title":"Late gadolinium enhancement imaging and sudden cardiac death","volume":"46","author":"Prasad","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2026.09.010_bib5","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCULATIONAHA.120.047640","article-title":"Prognostic value of nonischemic ringlike left ventricular scar in patients with apparently idiopathic nonsustained ventricular arrhythmias","volume":"143","author":"Muser","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/eurheartj\/eht510","article-title":"Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation","volume":"35","author":"Andreu","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2026.09.010_bib7","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jacc.2008.11.052","article-title":"Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate","volume":"53","author":"Bogun","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jcmg.2014.03.013","article-title":"CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia","volume":"7","author":"Piers","year":"2014","journal-title":"JACC, Cardiovasc Imaging"},{"key":"10.1016\/j.ipej.2026.09.010_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12968-023-00919-y","article-title":"Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy","volume":"25","author":"Cadour","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.ipej.2026.09.010_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.hrthm.2021.11.035","article-title":"Isolated critical epicardial arrhythmogenic substrate abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular tachycardia","volume":"19","author":"Tschabrunn","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ipej.2026.09.010_bib11","first-page":"1155","article-title":"Importance of the interventricular septum as part of the ventricular tachycardia substrate in nonischemic left ventricular cardiomyopathy","volume":"4","author":"Liang","year":"2018","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib12","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.hrthm.2011.03.008","article-title":"Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications","volume":"8","author":"Haqqani","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ipej.2026.09.010_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.0000083725.72693.EA","article-title":"Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia","volume":"108","author":"Hsia","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib14","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2026.09.010_bib15","first-page":"326","article-title":"Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study","volume":"21","author":"Augusto","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.ipej.2026.09.010_bib16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ipej.2026.09.010_bib18","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.126.050508","article-title":"Ventricular arrhythmia ablation in inherited cardiomyopathy: phenotype variability and outcomes based on functional genotypes","author":"Afzalian","year":"2026","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ipej.2026.09.010_bib20","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2021.08.039","article-title":"Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy","volume":"78","author":"Escobar-Lopez","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib21","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib23","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ipej.2026.09.010_bib25","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2026.09.010_bib26","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.09.010_bib27","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1093\/eurheartj\/ehad581","article-title":"Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines","volume":"44","author":"Wang","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2026.09.010_bib28","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC, Cardiovasc Imaging"},{"key":"10.1016\/j.ipej.2026.09.010_bib29","first-page":"1290","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"24","author":"Bravo","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib30","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ, Cardiovasc Imaging"},{"key":"10.1016\/j.ipej.2026.09.010_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib33","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/echo.13281","article-title":"Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction","volume":"33","author":"Murtagh","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.ipej.2026.09.010_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","article-title":"Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis","volume":"16","author":"Stevenson","year":"2023","journal-title":"JACC, Cardiovasc Imaging"},{"key":"10.1016\/j.ipej.2026.09.010_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2026.09.010_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ipej.2026.09.010_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd11070222","article-title":"Arrhythmic risk stratification in cardiac amyloidosis: a review of the current literature","volume":"11","author":"Bonvicini","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.ipej.2026.09.010_bib38","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib40","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ipej.2026.09.010_bib42","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American heart association\/american college of cardiology joint committee on clinical practice guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib43","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ipej.2026.09.010_bib44","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.09.010_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.09.010_bib47","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.09.010_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ, Cardiovasc Imaging"},{"key":"10.1016\/j.ipej.2026.09.010_bib49","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10840-017-0228-8","article-title":"Cardiac magnetic resonance imaging and electroanatomic voltage discordance in non-ischemic left ventricle ventricular tachycardia and premature ventricular depolarizations","volume":"49","author":"Betensky","year":"2017","journal-title":"J Intervent Card Electrophysiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib51","first-page":"1123","article-title":"Characterization of trans-septal activation during septal pacing: criteria for identification of intramural ventricular tachycardia substrate in Nonischemic cardiomyopathy","volume":"6","author":"Betensky","year":"2013","journal-title":"Circulation: Arrhythmia and Electrophysiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib52","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.0000083725.72693.EA","article-title":"Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia","volume":"108","author":"Hsia","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.09.010_bib53","first-page":"504","article-title":"Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation","volume":"6","author":"Gatzoulis","year":"2013","journal-title":"Circulation: Arrhythmia and Electrophysiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11437","article-title":"Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models","volume":"7","author":"Arevalo","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ipej.2026.09.010_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jelectrocard.2022.09.004","article-title":"Arrhythmia in hypertrophic cardiomyopathy: risk prediction using contrast enhanced MRI, T1 mapping, and personalized virtual heart technology","volume":"74","author":"O'Hara","year":"2022","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib56","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMc2517822","article-title":"Digital twin-guided ablation for ventricular tachycardia","volume":"394","author":"Chrispin","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.09.010_bib57","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacep.2024.04.028","article-title":"Distinct substrates of idiopathic ventricular fibrillation revealed by arrhythmia characteristics on implantable cardioverter-defibrillator","volume":"10","author":"Haissaguerre","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13073-024-01284-w","article-title":"The impact of damaging epilepsy and cardiac genetic variant burden in sudden death in the young","volume":"16","author":"Puckelwartz","year":"2024","journal-title":"Genome Med"},{"key":"10.1016\/j.ipej.2026.09.010_bib59","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00246-014-1082-4","article-title":"Post-mortem whole exome sequencing with gene-specific analysis for autopsy-negative sudden unexplained death in the young: a case series","volume":"36","author":"Narula","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.ipej.2026.09.010_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12864-022-09097-0","article-title":"Whole exome sequencing with a focus on cardiac disease-associated genes in families of sudden unexplained deaths in Yunnan, southwest of China","volume":"24","author":"Wei","year":"2023","journal-title":"BMC Genom"}],"container-title":["Indian Pacing and Electrophysiology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629226002457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629226002457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:57:53Z","timestamp":1791406673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0972629226002457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"alternative-id":["S0972629226002457"],"URL":"https:\/\/doi.org\/10.1016\/j.ipej.2026.09.010","relation":{},"ISSN":["0972-6292"],"issn-type":[{"value":"0972-6292","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodality assessment for sudden cardiac death risk stratification in non-ischemic cardiomyopathy: A case-based framework integrating cardiac magnetic resonance, electrophysiologic observations, and genetics","name":"articletitle","label":"Article Title"},{"value":"Indian Pacing and Electrophysiology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ipej.2026.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Heart Rhythm Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}